0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study

Journal of Periodontology
Carols SolísDeborah Violant

Abstract

The goal of this study is to evaluate the degree of staining and clinical efficacy of a chlorhexidine mouthwash with an antidiscoloration system (ADS) versus 0.2% chlorhexidine mouthwash (traditional). Secondary objectives are to evaluate the patient "compliance" factor according to patterns assigned by the clinician and to observe the side effects of the two mouthwashes. This comparative study is carried out on a sample of 15 non-smoking patients with chronic periodontitis at the Department of Periodontology, the International University of Catalunya, Barcelona, Spain. All patients used either 0.2% chlorhexidine mouthwash (control group = bottle B) or chlorhexidine with ADS (test group = bottle A) for 15 days. Each patient first rinsed with a randomly assigned mouthwash for 15 days followed by a 15-day washout period. Subsequently, each patient used a second mouthwash. Before each cycle, a full dental prophylaxis was performed. The plaque, gingival, and Brecx staining indexes were used. The results showed less tooth staining with the test group (P <0.01). No statistically significant differences were observed in plaque (P = 0.1496) and gingival indexes (P = 0.1688). Eighty-eight percent of patients followed the instructions ou...Continue Reading

References

Jan 1, 1989·The Journal of the American Dental Association·L F WolffC L Bandt
May 1, 1989·Journal of Clinical Periodontology·L G DePaolaC Niehaus
Apr 1, 1987·Journal of Clinical Periodontology·P Axelsson, J Lindhe
Nov 1, 1986·Journal of Clinical Periodontology·M Addy
May 1, 1985·Journal of Clinical Periodontology·H M EriksenJ E Ellingsen
Nov 1, 1985·Journal of Clinical Periodontology·J Wennström, J Lindhe
Nov 1, 1967·Journal of Periodontology·H Löe
Jul 1, 1982·Journal of Clinical Periodontology·J E EllingsenH M Eriksen
Apr 1, 1994·Journal of Clinical Periodontology·S JenkinsR G Newcombe
Sep 1, 1993·Journal of Clinical Periodontology·S JenkinsR J Newcombe
Jun 27, 1998·Periodontology 2000·C G Jones
Jun 27, 1998·Periodontology 2000·R J Jackson
Jun 23, 2000·Annals of Periodontology·G C Armitage
Jun 6, 2003·Journal of Clinical Periodontology·A Santos
Dec 1, 1963·Acta Odontologica Scandinavica·H LOE, J SILNESS
Aug 28, 2004·Periodontology 2000·Tatsuji Nishihara, Takeyoshi Koseki
Feb 3, 2006·International Journal of Dental Hygiene·M AddyJ Moran
Feb 3, 2006·International Journal of Dental Hygiene·F BernardiL Montebugnoli
Apr 26, 2006·Journal of Clinical Periodontology·Nicole B ArweilerThorsten M Auschill

❮ Previous
Next ❯

Citations

Jun 20, 2015·Journal of Clinical Periodontology·John T GallobRoberto Labella
May 19, 2012·International Journal of Dental Hygiene·N W D van Maanen-SchakelG A Van der Weijden
May 18, 2017·Brazilian Oral Research·Gabriela Otero Dos SantosPatricia Weidlich
Oct 4, 2019·Therapeutic Advances in Drug Safety·Gianluca M TartagliaConchita Martín

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.